Trials / Completed
CompletedNCT00376402
Study of a Pandemic Influenza Vaccine in Elderly Participants
Phase II Study of a Pandemic Influenza Vaccine in Elderly Participants
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 200 (planned)
- Sponsor
- Seqirus · Industry
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
The World Health Organisation has warned that an influenza pandemic is inevitable. The avian influenza H5N1 virus strain is one of the leading candidates to cause the next influenza pandemic. The elderly are likely to be a special target group for vaccination; therefore, this study will test the safety and immunogenicity of a H5N1 pandemic influenza vaccine in a healthy elderly population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | H5N1 Pandemic Influenza Vaccine |
Timeline
- Start date
- 2006-10-01
- Completion
- 2007-06-01
- First posted
- 2006-09-14
- Last updated
- 2016-07-19
Locations
2 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT00376402. Inclusion in this directory is not an endorsement.